1. HOME
  2. Company
  3. HISTORY

COMPANY

会社案内

HISTORY

沿革

In the cutting-edge medical field, a Japanese venture company – TOKIWA-Bio, sets goal to contribute to the world!

HISTORY

201310

“Practical application of clinical iPS cell production technology” adopted for Program for Creating STart-ups from Advanced Research and Technology (START)

201412

TOKIWA-Bio Inc. was established.

20153

Recognized by AIST as AIST start-ups and established headquarters and research facility in AIST Tsukuba Central Office

201611

Head office moved to Tsukuba Center Inc.(TCI)

201711

TOKIWA-Bio Inc. raised 330 million yen through third-party allotment.

201810

TOKIWA-Bio Inc. was adopted by Japan Agency for Medical Research and Development(AMED) Project for “Genetic and Cellular Therapeutic Research and Development”

20198

TOKIWA-Bio Inc. was adopted by Japan Agency for Medical Research and Development(AMED) Project for “Basic Technology Development for Industrialization of Regenerative Medicine and Gene Therapy(regenerative medicine seeds development acceleration support)”